Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors

World Journal of Gastroenterology

Volumn 11, Issue 40, 2005, Pages 6373-6380

  Lu, Yen Shen ^a   Lien, Huang Chun ^a   Yeh, Pen Yen ^a   Yeh, Kun Huei ^a   Kuo, Min Liang ^a   Kuo, Sung Hsin ^a   Cheng, Ann Lii ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Carcinoma; Cell growth; Chemosensitivity; Drug resistance; Glucocorticoid receptor; Glucocorticoids

Indexed keywords

CISPLATIN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA; CARCINOMA CELL; CELL HETEROGENEITY; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CARCINOMA;

EID: 29544451180     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i40.6373     Document Type: Article

References (45)

1. Frankfurt O, Rosen ST. Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol 2004; 16: 553-563
2. Wright AP, Zilliacus J, McEwan IJ, Dahlman-Wright K, Almlof T, Carlstedt-Duke J. Structure and function of the glucocorticoid receptor. J Steroid Biochem Mol Biol 1993; 47: 11-19
3. Schwartzman RA, Cidlowski JA. Glucocorticoid-induced apoptosis of lymphoid cells. Int Arch Allergy Immunol 1994; 105: 347-354
4. McEwan IJ, Wright AP, Gustafsson JA. Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays 1997; 19: 153-160
5. Rogatsky I, Trowbridge JM, Garabedian MJ. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol Cell Biol 1997; 17: 3181-3193
6. Samuelsson MK, Pazirandeh A, Davani B, Okret S. p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells. Mol Endocrinol 1999; 13: 1811-1822
7. Greenberg AK, Hu J, Basu S, Hay J, Reibman J, Yie TA, Tchou-Wong KM, Rom WN, Lee TC. Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. Am J Res Cell & Mol Biol 2002; 27: 320-328
8. Wolff JE, Denecke J, Jurgens H. Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells. AntiCancer Res 1996; 16: 805-809
9. Chang TC, Hung MW, Jiang SY, Chu JT, Chu LL, Tsai LC. Dexamethasone suppresses apoptosis in a human gastric cancer cell line through modulation of bcl-x gene expression FEBS Lett 1997; 415: 11-15
10. Naumann U, Durka S, Weller M. Dexamethasone-mediated protection from drug cytotoxicity: association with p21 WAF1/CIP1 protein accumulation? Oncogene 1998; 17: 1567-1575
11. Benckhuijsen C, Osman AM, Hillebrand MJ, Smets LA. Glucocorticoid effect on melphalan cytotoxicity, cell-cycle position, cell size, and [3H]uridine incorporation in one of three human melanoma cell lines. Cancer Res 1987; 47: 4814-4820
12. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 2004; 64: 1757-1764
13. Wang H, Li M, Rinehart JJ, Zhang R. Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy. Clin Cancer Res 2004; 10: 1633-1644
14. Yang CH, Schneider E, Kuo ML, Volk EL, Rocch E, Chen YC. BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochem. Pharmacol 2000; 60: 831-837
15. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JKC, Hsu MM, Chuang SM. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Investig 1990; 62: 713-724
16. Lin CT, Chan WY, Chen W, Huang HM, Wu HC, Hsu MM, Chuang SM, Wang CC. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Investig 1993; 68: 716-727
17. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47: 936-942
18. Harmon JM, Thompson EB. Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-CT. Mol Cell Biol 1981; 1: 512-521
19. Scheidereit C, Geisse S, Westphal HM, Beato M. The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature 1983; 304: 749-752
20. Lippman ME, Yarbro GK, Leventhal BG. Clinical implications of glucocorticoid receptors in human leukemia. Cancer Res 1978; 38: 4251-4256
21. Vanderbilt J N, Miesfeld R, Maler BA, Yamamoto KR. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1987; 1: 68-74
22. Gehring U, Mugele K, Ulrich J. Cellular receptor levels and glucocorticoid responsiveness of lymphoma. cells. Mol Cell Endocrinol 1984; 36: 107-113
23. Bourgeois S, Newby RF. Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines. Cell 1977; 11: 423-430
24. Chapman MS, Askew DJ, Kuscuoglu U, Miesfelt RL. Transcritional control of steroid-regulated apoptosis in murine thymoma cells. Mol Endocrinol 1996; 10: 967-978
25. Bloomfield CD, Smith KA, Peterson BA, Munck A. Glucocorticoid receptors in adult acute lymphoblastic leukemia. Cancer Res 1981; 41: 4857-4860
26. Pui CH, Dahl GV, Rivera G, Murphy SB, Costlow ME. The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. Leuk Res 1984; 8: 579-585
27. Pui CH, Costlow ME. Sequential studies of lymphoblast glucocorticoid receptor levels at diagnosis and relapse in childhood leukemia: an update. Leuk Res 1986; 10: 227-229
28. Wells RJ, Mascaro K, Young PC, Cleary RE. Glucocorticoid receptors in the lymphoblasts of patients with glucocorticoid-resistant childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 1981; 3: 259-264
29. Powers JH, Hillmann AG, Tang DC, Harmon JM. Cloning and expression of mutant glucocorticoid. receptors from glucocorticoid-sensitive and glucocorticoid-resistant human leukemic cells. Cancer Res 1993; 53: 4059-4065
30. Ashraf J, Thompson EB. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes. Mol Endocrinol 1993; 7: 631-642
31. Buttgereit F, Saag KG, Cutolo M, da Silva JA, Bijlsma JW. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol 2005; 34: 14-214
32. McKenna NJ, Lanz RB, O'malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocr Reviews 1999; 20: 321-344
33. Beato M, Chavez S, Truss M. Transcriptional regulation by steroid hormones. Steroids 1996; 61: 240-251
34. Reichardt HM, Schutz G. Glucocorticoid signaling-multiple variations of a common theme. Mal Cell Endocrinol 1998; 146: 1-6
35. McEwan IJ, Wright APH, Gustafsson JÅ. Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays 1997; 19: 153-160
36. Dumont A, Helmer SP, Schmitz ML, Gustafsson JÅ, Liden J, Okret S, van der Saag PT, Wissink S, van der Burg B, Herrlich P, Haegeman G, De Bosscher K, Fiers W. Cross-talk between steroids and NF-k: what language? Trends Biochem. Sci 1998; 23: 233-235
37. Gottlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 1998; 76: 480-489
38. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappa B. Science 1996; 274: 787-789
39. Wang CY, Mayo MW, Baldwin AS. TNF-alpha and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 1996; 274: 784-787
40. Chuang SE, Yeh PY, Lu YS, Lai GM, Liao CM, Gao M, Cheng AL. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem Pharmacol 2002; 63: 1709-1716
41. Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res 1979; 39: 1447-1454
42. Liu SH, Otal-Brun M, Webb TE. Glucocorticoid receptors in human tumors. Cancer Lett 1980; 10: 269-275
43. Smith RA, Lea RA, Curran JE, Weinstein SR, Griffiths LR Expression of glucocorticoid and progesterone nuclear receptor genes in archival breast cancer tissue. Breast Cancer Res 2003; 5: R9-12
44. Weijtens O, Schoemaker RC, Cohen AF, Romijn FP, Lentjes EG, Van Rooij J. Dexamethasone concentration in vitreous and serum after oral administration. Am J Ophthalmol 1998; 125: 673-679
45. Brady ME, Sartiano GP, Rosenblum SL, Zaglama NE, Bauguess CT. The pharmacokinetics of single high doses of dexamethasone. Eur J Clin Pharmacol 1987; 32: 593-596